Articles
Is open collaboration the future for R&D?

Is open collaboration the future for R&D?

We speak with Chris Molloy about the benefits of open collaboration in R&D and how IT can support these developments. The pharma industry is constantly changing and it’s no secret that to keep up with these changes, organisations today have to...

Articles
Device ad-vice: experience is the best teacher

Device ad-vice: experience is the best teacher

In the fourth part of our “Device ad-vice” series, Nancy Beesley looks at the value of experience in device marketing. A key goal of this series is to address the differences between device marketing and pharma marketing...

Articles
Effective discount tactics drive increased adherence and brand loyalty among patients and providers

Effective discount tactics drive increased adherence and bra...

Kelly Renfro explores how we can increase patient adherence in addition to brand loyalty with treatment discount tactics. Even before some of the recent high profile patent expirations, the rate of generic drug use has continued to rise. In fact, recent reports...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. ESMO26: Tango sees 82% ORR with combo in pancreatic cancer
  2. Roche offers $15bn for strategic-level deal with Hansoh
  3. ESMO26: Moderna, MSD reveal cancer jab data early after leak
  4. Clinical trial setup times fall sharply in UK
  5. Despite US policy changes, drug prices stay stubbornly high

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more